Capillus Premiered Its Full Line of Laser Therapy Caps During Its Debut at Medica 2017 World Forum for Medicine
Medica 2017 in Dusseldorf, Germany a Huge Success for Capillus
MIAMI (PRWEB) November 21, 2017
As a first-time attendee to Medica 2017, we took great pleasure in meeting with leading suppliers of medical technology and introducing Capillus as an innovator of laser therapy caps
Capillus, LLC asserted itself as a leading provider of hair restoration therapy devices to global medical technology suppliers during the Medica 2017 World Forum for Medicine. Billed as the “world’s biggest medical trade fair and the international leading specialist trade fair for the supplier market for the medical technology industry,” according to its website, Medica 21017 was held in Dusseldorf, Germany from November 13th to November 16th, 2017.
Capillus presented its complete line of laser therapy caps for treating pattern baldness, clinical hair care products, keratin hair fibers, and Minoxidil spray during its debut in Medica 2017.
Capillius was especially proud to introduce the recently released CapillusRX™ which contains more lasers than any low-level laser therapy device in the market for home treatment of hair loss. Its 312 diodes provide maximum simultaneous coverage of the scalp by any device for treatment of hereditary hair loss. It is available only through the company’s global physician network.
Attending Medica 2017 was Capillus’ international team which was led by Capillus’ Chief Executive Officer, Carlos Piña and consisted of Chief Operating Officer, Maria Piña, Director of International Sales, Fernando Bermudez, and Director of International Distribution, Lisa Weaver.
“As a first-time attendee to Medica 2017, we took great pleasure in meeting with leading suppliers of medical technology and introducing Capillus as an innovator of laser therapy caps which are clinically-proven to treat pattern baldness in men and women,” said Carlos Piña, Capillus Chief Executive Officer, “overall, I think our initial presence at Medica was a huge success.”
Capillus met with medical technology distributors and suppliers from around the world including Saudi Arabia, Singapore, Malyaisa, Egypt, India, and Russia during the Medica 2017 World Forum for Medicine.
In addition to its CapillusRX™ available only through its physician network, Capillus currently offers three FDA-Cleared laser caps for direct sale via http://www.capillus.com: 1) Capillus82™, an economical and convenient device with 82 laser diodes, 2) Capillus202™, a powerful yet affordable device containing 202 laser diodes, as well as 3) CapillusPRO™, a professional-grade device with 272 laser diodes. Capillus laser therapy caps use Low Level Laser Therapy technology (LLLT), which is a non-invasive and chemical-free medical treatment for hair loss. The Capillus laser therapy caps use a six-minute protocol which greatly reduces the time it takes to receive treatment. Capillus laser therapy caps are manufactured in the USA from foreign-source raw materials. The Capillus facility is ISO 13485 compliant, and it is located in Miami, Florida.
About Capillus, LLC
Capillus, LLC offers prescription and over-the-counter hair regrowth products and medical devices for both men and women suffering from hair loss. The Capillus premiere product lines include low-level laser therapy (LLLT) devices that are FDA-cleared and manufactured in the US under the highest-quality certification standard for the medical device industry (ISO13485). Capillus also offers additional non-prescription clinical hair products for hair and scalp health. Capillus products are available directly to the public for at-home use and also to their network of physicians for office use.
For more information visit https://www.capillus.com.